Switch to:
More From Other Websites
FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application with New Data in... Dec 24 2014
Beta-Amyloid: The Emperor Really Does Have No Clothes Dec 20 2014
ImmunoGen's stock plunges after Roche's disappointing trial results prompts downgrade Dec 19 2014
Bina Technologies is acquired by Roche. Dec 19 2014
Roche Drugs For Alzheimer's, Breast Cancer Disappoint Dec 19 2014
Genentech Provides Update on Phase III MARIANNE Study in People with Previously Untreated Advanced... Dec 19 2014
Roche launches PCR molecular diagnostic system for point of care environment Dec 16 2014
Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results Dec 15 2014
Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results Dec 15 2014
Genentech Submits New Drug Application to FDA for Investigational Cobimetinib Used in Combination... Dec 15 2014
Merck Reveals Data from Breast Cancer Study on Keytruda Dec 11 2014
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties Dec 11 2014
Roche (RHHBY) Presents Positive Data on Haemophilia Drug Dec 10 2014
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) Dec 10 2014
Merck's Keytruda Might Treat Virulent Breast Cancer Dec 10 2014
Roche Diagnostics purchases tissue dissection technology from AvanSci Bio Dec 10 2014
Pharmacyclics Presents Imbruvica Data at the ASH Meeting Dec 09 2014
Celgene Up on Positive Revlimid Data Presented at ASH Dec 09 2014
ImmunoGen Reports Encouraging Data on Cancer Drug Dec 08 2014
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH Dec 08 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Steve.dunfield@google
ReplySteve.dunfield@google - 8 months ago
Adjust for split?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK